Mohsen Beheshti

Department of Nuclear Medicine and Endocrinology, PET-CT Center Linz, St Vincent's Hospital, Linz / Department of Nuclear Medicine, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria

[ 1 ] - The potential value of F-18 FDG PET in comparison to ct in early prediction of response to Imatinib (STI571) therapy in patients with gastrointestinal stromal tumors

Introduction: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GIST has been shown to over-express c-KIT (CD117), the receptor tyrosine kinase. Imatinib (STI571 or Glivec) is a new type of tyrosine kinase inhibitor that selectively inhibits various tyrosine kinases and has been successfully used to trea...

Co-Authors